Literature DB >> 11001603

Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults.

B S McCann1, L Scheele, N Ward, P Roy-Byrne.   

Abstract

The authors examined the factor structure and discriminant validity of the Wender Utah Rating Scale (WURS) in adults seeking evaluation for attention-deficit/hyperactivity disorder (ADHD). Three factors (Dysthymia, Oppositional/Defiant Behavior, and School Problems) accounted for 59.4% of the variance. In a stepwise discriminant function analysis, age and childhood school problems emerged as significant variables. The classification procedure correctly classified 64.5% of patients. Among those who did not have ADHD, only 57.5% were correctly classified compared with 72.1% among those with ADHD. The WURS is sensitive in detecting ADHD, but it misclassifies approximately half of those who do not have ADHD.

Entities:  

Mesh:

Year:  2000        PMID: 11001603     DOI: 10.1176/jnp.12.2.240

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  23 in total

Review 1.  Smoking behavior characteristics of non-selected smokers with childhood attention-deficit/hyperactivity disorder (AD/HD) history: a systematic review and meta-analysis.

Authors:  Guillaume Fond; Anderson Loundou; Sebastien Guillaume; Xavier Quantin; Alexandra Macgregor; Régis Lopez; Philippe Courtet; Paquito Bernard; Daniel Bailly; Mocrane Abbar; Marion Leboyer; Laurent Boyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-03-12       Impact factor: 5.270

2.  Bipolar disorder comorbid with attention-deficit/hyperactivity disorder in adult inpatients with acute relapse.

Authors:  Alina Marin; Duncan Scott; Dianne L Groll
Journal:  Prim Care Companion CNS Disord       Date:  2013-07-04

3.  [Attention deficit-hyperactivity disorder (ADHD) and comorbid mental disorders : ADHD-specific self-rating scales in differential diagnostics].

Authors:  M Paucke; T Stark; C Exner; C Kallweit; U Hegerl; M Strauß
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

4.  Attention-deficit/hyperactivity disorder: presentation and management in the Haitian American child.

Authors:  Nicole Prudent; Peggy Johnson; Jennifer Carroll; Larry Culpepper
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

5.  [Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder].

Authors:  P Retz-Junginger; W Retz; D Blocher; R-D Stieglitz; T Georg; T Supprian; P H Wender; M Rösler
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

6.  Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder.

Authors:  Tiffany A Greenwood; Eun-Jeong Joo; Tatyana Shekhtman; A Dessa Sadovnick; Ronald A Remick; Paul E Keck; Susan L McElroy; John R Kelsoe
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-12-19       Impact factor: 3.568

7.  Assessing methylphenidate preference in ADHD patients using a choice procedure.

Authors:  Emily MacDonald Fredericks; Scott H Kollins
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

8.  Psychometric properties of the Chinese version of the adult ADHD Self-report Scale.

Authors:  Chin-Bin Yeh; Susan Shur-Fen Gau; Ronald C Kessler; Yu-Yu Wu
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

9.  Attention deficit hyperactivity disorder symptoms, type of offending and recidivism in a prison population: The role of substance dependence.

Authors:  Jan C Román-Ithier; Rafael A González; María C Vélez-Pastrana; Gloria M González-Tejera; Carmen E Albizu-García
Journal:  Crim Behav Ment Health       Date:  2016-07-26

10.  Comparing Methods to Determine Persistence of Childhood ADHD Into Adulthood: A Prospective, Population-Based Study.

Authors:  William J Barbaresi; Amy L Weaver; Robert G Voigt; Jill M Killian; Slavica K Katusic
Journal:  J Atten Disord       Date:  2015-12-22       Impact factor: 3.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.